We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice.
- Authors
Beichu Guo; Chang, Elmer Y.; Genhong Cheng; Guo, Beichu; Cheng, Genhong
- Abstract
IFN-beta, a type I IFN, is widely used for the treatment of MS. However, the mechanisms behind its therapeutic efficacy are not well understood. Using a murine model of MS, EAE, we demonstrate that the Th17-mediated development of autoimmune disease is constrained by Toll-IL-1 receptor domain-containing adaptor inducing IFN-beta-dependent (TRIF-dependent) type I IFN production and its downstream signaling pathway. Mice with defects in TRIF or type I IFN receptor (IFNAR) developed more severe EAE. Notably, these mice exhibited marked CNS inflammation, as manifested by increased IL-17 production. In addition, IFNAR-dependent signaling events were essential for negatively regulating Th17 development. Finally, IFN-beta-mediated IL-27 production by innate immune cells was critical for the immunoregulatory role of IFN-beta in the CNS autoimmune disease. Together, our findings not only may provide a molecular mechanism for the clinical benefits of IFN-beta in MS but also demonstrate a regulatory role for type I IFN induction and its downstream signaling pathways in limiting Th17 development and autoimmune inflammation.
- Publication
Journal of Clinical Investigation, 2008, Vol 118, Issue 5, p1680
- ISSN
0021-9738
- Publication type
Academic Journal
- DOI
10.1172/JCI33342